I can't really comment other than it was delayed due to the COH negotiations. Lung cancer certainly showed promise in the Oncolines screen.
Lung cancer is now covered by the "all comers" trial so if we see a great response in the Phase 1a/b trial then there could be a seperate sub-trial specifically for lung cancer in the Phase 2 umbrella trial. The aim is to let the drug tell us the best indications to pursue, rather than us having to guess. The drug never gets it wrong unlike us humans
Ann: Updated Strategy and Investor Presentation, page-394
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |